KIT and acute myeloid leukemia: Consistently, chlorpromazine (CPZ), an antipsychotic that disrupts CCV formation, markedly inhibited proliferation of FLT3-ITD- or c-KIT V617F-positive AML cells, while sparing cells with wild-type FLT3 and c-KIT.